📷 Image: Wikimedia Commons / Crystal
International
US Imposes Tariffs on Generic Medicines, India’s Pharma Sector Faces New Challenges
✍️ Hindustan Times
🗓 22 Jul 2026, 03:10 PM
👁 3
The United States has announced new tariffs on generic medicines, a move that could have significant implications for India's pharmaceutical exports. The policy may raise costs and alter market dynamics for Indian drug manufacturers.
The United States has announced tariffs on generic medicines, a decision that has drawn attention from global pharmaceutical markets. India, which supplies a large share of the world’s generic drugs, may see changes in its export dynamics as a result. The new tariffs could increase the cost of Indian medicines in the U.S. market, potentially affecting pricing and competitiveness. Indian industry officials are closely monitoring the developments and are preparing to engage with policymakers to mitigate adverse impacts.